Boundless Bio, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Boundless Bio, Inc. has issued a proxy statement detailing the agenda for its 2026 Annual Meeting of Stockholders, including director elections and auditor ratification.
NASDAQ
Boundless Bio will hold its annual stockholders meeting on June 23, 2025, to elect directors and ratify the appointment of KPMG LLP as its independent auditor.
NASDAQ
Boundless Bio will hold its 2025 Annual Meeting of Stockholders on June 23, 2025, to elect directors and ratify the appointment of KPMG LLP as its independent accounting firm.